Suppr超能文献

系统性红斑狼疮患者血液中BDCA - 2 +(淋巴样)和CD11c +(髓样)树突状细胞减少。

Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.

作者信息

Migita K, Miyashita T, Maeda Y, Kimura H, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K

机构信息

Clinical Research Centre, NHO Nagasaki Medical Centre, Omura, Japan.

出版信息

Clin Exp Immunol. 2005 Oct;142(1):84-91. doi: 10.1111/j.1365-2249.2005.02897.x.

Abstract

Type 1 IFN is thought to be implicated in the autoimmune process of SLE. Plasmacytoid dendric cells (DC), which are natural IFN-alpha producing cells, play a pivotal epipathogenic role in SLE. The present study was undertaken to investigate the phenotypic characteristics of peripheral blood DC in SLE patients in comparison with those of healthy controls. Samples from 20 SLE patients and 18 healthy controls were studied. Three-colour flow cytometry was performed to identify myeloid DC, as CD11c(+) lineage marker(-), and HLA-DR(+) cells and plasmacytoid DC, as BDCA-2(+) linage marker(-), and HLA-DR(+) cells. We used the whole blood 'lyse/no-wash' procedure, which allows precise counting of peripheral blood DC. BDCA-2(+) plasmacytoid DC and CD11c(+) myeloid DC were reduced in SLE patients compared with controls. Similarly, BDCA-3(+) DC were reduced in SLE patients. These results indicated that SLE patients had a reduced number of both BDCA-2(+) plasmacytoid DC and CD11c(+) myeloid DC. These alternations of the DC subset may drive the autoimmune response in SLE.

摘要

1型干扰素被认为与系统性红斑狼疮(SLE)的自身免疫过程有关。浆细胞样树突状细胞(DC)是天然产生干扰素-α的细胞,在SLE中起关键的致病作用。本研究旨在比较SLE患者与健康对照者外周血DC的表型特征。研究了20例SLE患者和18例健康对照者的样本。采用三色流式细胞术鉴定髓样DC,即CD11c(+)谱系标志物(-)和HLA-DR(+)细胞,以及浆细胞样DC,即BDCA-2(+)谱系标志物(-)和HLA-DR(+)细胞。我们采用全血“裂解/不洗涤”程序,该程序可精确计数外周血DC。与对照组相比,SLE患者中BDCA-2(+)浆细胞样DC和CD11c(+)髓样DC减少。同样,SLE患者中BDCA-3(+)DC也减少。这些结果表明,SLE患者中BDCA-2(+)浆细胞样DC和CD11c(+)髓样DC的数量均减少。DC亚群的这些改变可能驱动SLE中的自身免疫反应。

相似文献

1
Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.
Clin Exp Immunol. 2005 Oct;142(1):84-91. doi: 10.1111/j.1365-2249.2005.02897.x.
2
Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
J Immunol Methods. 2010 Oct 31;362(1-2):168-75. doi: 10.1016/j.jim.2010.09.031. Epub 2010 Oct 1.
4
Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Arthritis Rheum. 2001 Apr;44(4):856-65. doi: 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A.
6
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
Leukemia. 2006 Apr;20(4):645-9. doi: 10.1038/sj.leu.2404146.
7
8
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
Ann Rheum Dis. 2010 Jul;69(7):1370-7. doi: 10.1136/ard.2009.111021. Epub 2009 Oct 22.

引用本文的文献

1
Dendritic cell heterogeneity and its role in connective tissue diseases.
Inflamm Regen. 2025 Jul 28;45(1):24. doi: 10.1186/s41232-025-00388-z.
2
The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension.
Front Immunol. 2024 Sep 17;15:1464762. doi: 10.3389/fimmu.2024.1464762. eCollection 2024.
4
CSL362 potently and specifically depletes pDCs and ablates SLE-immune complex-induced IFN responses.
iScience. 2023 Jun 20;26(7):107173. doi: 10.1016/j.isci.2023.107173. eCollection 2023 Jul 21.
5
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.
Cell Rep Med. 2023 May 16;4(5):101036. doi: 10.1016/j.xcrm.2023.101036.
6
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Clin Exp Med. 2023 Jul;23(3):803-813. doi: 10.1007/s10238-022-00866-5. Epub 2022 Aug 11.
7
Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus.
Front Immunol. 2022 Jun 27;13:888501. doi: 10.3389/fimmu.2022.888501. eCollection 2022.
8
Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
Inflamm Res. 2022 Jun;71(5-6):537-554. doi: 10.1007/s00011-022-01554-6. Epub 2022 Mar 17.
10
IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
JCI Insight. 2020 Jan 30;5(2):124020. doi: 10.1172/jci.insight.124020.

本文引用的文献

1
Autoimmunity through cytokine-induced dendritic cell activation.
Immunity. 2004 May;20(5):539-50. doi: 10.1016/s1074-7613(04)00108-6.
4
Tolerogenic dendritic cells.
Annu Rev Immunol. 2003;21:685-711. doi: 10.1146/annurev.immunol.21.120601.141040. Epub 2001 Dec 19.
5
The natural interferon-alpha producing cells in systemic lupus erythematosus.
Hum Immunol. 2002 Dec;63(12):1181-93. doi: 10.1016/s0198-8859(02)00757-7.
6
Blood dendritic cells and DC-poietins in systemic lupus erythematosus.
Hum Immunol. 2002 Dec;63(12):1172-80. doi: 10.1016/s0198-8859(02)00756-5.
10
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
Science. 2001 Nov 16;294(5546):1540-3. doi: 10.1126/science.1064890.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验